pembrolizumabmRNA-4359Moderna, Inc.CPI-R/R melanomamelanomaNCT05533697
…7), as of 28Feb2025, 29 patients with CPI-R/R melanoma received pembrolizumab (400 mg IV Q6W) plus mRNA-4359 (400 µg [n=14] or 1000 µg [n=15]…
1articles mentioning drugs
5drug mentions
1distinct drugs extracted
0%of mentions human-reviewed
Active filtersEntity: mRNA-4359 ×
mRNA-4359
This drug is selected. Its supporting articles are shown below.